That came in agreement with HA-SMA-NMS that effectively delivered CDF to the aggressive CD44+ stem-like pancreatic cancer cells [46] and HA-TPGS-DOX that increased doxorubicin cytotoxicity in MCF-7/ADR [47]. The gene discussed is CD44; the disease is familial pancreatic carcinoma.